Securities law firm Hagens Berman Sobol Shapiro LLP has launched an investigation into potential securities fraud by Metropolitan Bank Holding Corp (NYSE: MCB) following disappointing Q2 2026 results.

The probe examines whether management misled investors regarding credit risks during early 2026, adding to scrutiny from Pomerantz LLP.

Investigation Focus

Hagens Berman alleges that Metropolitan and certain officers or directors may have engaged in unlawful business practices. The investigation centers on the July 21, 2026 earnings release, where the bank reported revenue and GAAP net income below analyst expectations.

Key concerns highlighted by Hagens Berman include:

• Provisioning Spike: Credit loss provisions more than doubled to $13.3 million. Management attributed this surge to difficulties with a single commercial and industrial (C&I) loan and the charge-off of a commercial real estate loan.
• Stock Decline: Following the results, shares fell $8.88 per share, or 8.96%, closing at $90.19 on July 22, 2026.

Hagens Berman Probe Details

Hagens Berman’s parallel investigation focuses on earlier disclosures from the Q1 earnings call and Annual General Meeting. Executives reportedly characterized credit issues as a contained "speed bump" involving only five specific credits and stated the bank was "adequately reserved."

The firm highlights a divergence between these assurances and Q2 realities:

• Reserve Adequacy: Despite claims of adequate reserves, the bank recorded $14 million in unexpected new charge-offs, including $10 million for C&I loans, $4 million for a high-net-worth exposure, and a separate $10 million charge-off for a window and door manufacturer.
• Portfolio Health: Earnings were impacted by isolated items, including a new $26 million C&I non-performing loan.
• Loan Resolutions: A Kansas City loan settlement resulted in only partial reimbursement of legal fees, contradicting guidance for full recovery.

Financial Impact

Metropolitan Bank reported Q2 2026 EPS of $1.54, missing consensus estimates of roughly $2.28. The miss was driven by severe spikes in credit loss provisions and unexpected write-downs.

What the Numbers Show

The divergence between the $1.54 actual EPS and the $2.28 consensus estimate underscores the severity of the unanticipated credit charges. The $14 million in unexpected charge-offs directly contradicted the "adequately reserved" narrative presented to investors months prior, suggesting that risk exposure was broader than disclosed.

Investor Action

Investors who purchased MCB securities and suffered losses are encouraged to contact either firm.

• Pomerantz LLP: Contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
• Hagens Berman: Contact Reed Kathrein at MCB@hbsslaw.com or 844-916-0895. Investors may also submit information via the firm’s website. Whistleblowers with non-public information may consider options under the SEC Whistleblower program.

Pomerantz LLP has joined an ongoing securities fraud investigation into Metropolitan Bank Holding Corp (NYSE: MCB), intensifying legal scrutiny following the company’s second quarter 2026 earnings release on July 21, 2026. The inquiry focuses on whether Metropolitan and its officers or directors engaged in unlawful business practices or failed to provide accurate information regarding financial health, particularly concerning credit risk disclosures. This development comes after the company reported revenue and GAAP net income that fell short of analyst expectations, triggering an immediate market reaction. Consequently, the stock price fell $8.88 per share, or approximately 8.96%, to close at $90.19 per share on July 22, 2026. Investors who suffered losses due to alleged misstatements or omissions prior to the earnings announcement may be eligible to participate in the class action.

Investigation Scope

The investigation by Pomerantz LLP is concurrent with probes by Schall, Brown & Schwartz LLP (SBS) and Lowey Dannenberg, P.C., all of which are examining similar claims related to the same earnings period. Pomerantz LLP, acknowledged as one of the premier firms in corporate and securities class litigation, is seeking shareholders who purchased Metropolitan Bank Holding Corp securities during the relevant trading period. Danielle Peyton at Pomerantz LLP can be contacted at newaction@pomlaw.com or 646-581-9980, ext. 7980, for eligibility assessments. The firms are collectively challenging the adequacy of pre-earnings disclosures concerning credit quality and loan performance.

Financial Drivers of Decline

The primary catalyst for the market reaction was a sharp increase in provisioning for credit losses, which more than doubled to $13.3 million. Management attributed this surge to difficulties associated with a single commercial and industrial loan, alongside a charge-off for a commercial real estate loan. These credit events significantly impacted GAAP net income, leading to the underperformance against analyst forecasts. The concentration of risk in specific loan segments highlights vulnerabilities in the bank’s portfolio that were not fully anticipated by the market.

Shareholder Impact

The drop in share price resulted in immediate unrealized losses for investors holding Metropolitan Bank Holding Corp securities on July 22, 2026. Pomerantz LLP emphasizes its role in fighting for victims of securities fraud and corporate misconduct, having recovered numerous multimillion-dollar damages awards on behalf of class members. The involvement of multiple law firms signals a broader legal challenge regarding the bank's operational performance and disclosure practices during the period.